Steven Galson
Director/Board Member at BIOCRYST PHARMACEUTICALS, INC.
Net worth: 150 424 $ as of 2024-03-30
Profile
Steven K.
Galson is currently serving as an Independent Director at BioCryst Pharmaceuticals, Inc. since 2021 and at Elephas Biosciences Corp.
since 2022.
Previously, he held positions as an Independent Director at Vanda Pharmaceuticals, Inc. from 2011 to 2015, Director at The National Board of Medical Examiners, Inc., Deputy Director at the Center for Drug Evaluation & Research, Director-Science Coordination & Policy Office at the United States Environmental Protection Agency, and Independent Director at InSilico Medicine Hong Kong Ltd.
He also served as the Director of the US Food & Drug Administration from 2001 to 2007 and as the Senior VP-Global Regulatory Affairs & Safety at Amgen, Inc. from 2014 to 2021.
Additionally, he held positions such as Senior Vice President-Civilian Health Operations at Leidos, Inc. in 2010, Chief Health Scientist at Science Applications International Corp., Chief Medical Officer at the Environmental Protection Agency and the US Department of Energy, and Chief Operating Officer at ProQR Therapeutics NV from 2021 to 2022.
Dr. Galson obtained his undergraduate degree from Stony Brook University, a doctorate from the Icahn School of Medicine at Mount Sinai in 1983, and a graduate degree from Harvard T.H.
Chan School of Public Health in 1990.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-12 | 29,611 ( 0.01% ) | 150 424 $ | 2024-03-30 |
Steven Galson active positions
| Companies | Position | Start |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Director/Board Member | 2021-08-31 |
Elephas Biosciences Corp.
 Elephas Biosciences Corp. Medical/Nursing ServicesHealth Services Elephas Biosciences Corp. is a live tumor imaging company that provides cancer diagnostic solutions to predict treatment outcomes and accelerate drug development. The company is based in Madison, WI and was founded by Maneesh K. Arora, who has been the CEO since incorporation. The company's revolutionary diagnostic platform brings insights to cancer treatment decisions and accelerates immuno-oncology drug development. Investors can learn about clinical trials aimed at predicting responses to immunotherapy and how immunotherapeutic drug development can be accelerated with Elephas Biosciences's cybrid. | Director/Board Member | 2022-07-27 |
Former positions of Steven Galson
| Companies | Position | End |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Chief Operating Officer | 2022-09-30 |
| VANDA PHARMACEUTICALS INC. | Director/Board Member | 2015-06-17 |
Leidos, Inc.
 Leidos, Inc. Information Technology ServicesTechnology Services Leidos, Inc. provides scientific, engineering, systems integration and technical services and solutions. It offers solutions and services that leverage the power of data analytics, systems integration, and cyber security across national security, health, and engineering markets. The company was founded by John Robert Beyster in June 1969 and is headquartered in Reston, VA. | Corporate Officer/Principal | 2010-09-30 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Director/Board Member | 2006-12-31 |
The National Board of Medical Examiners, Inc.
 The National Board of Medical Examiners, Inc. Medical/Nursing ServicesHealth Services The National Board of Medical Examiners, Inc. provides services to the public through its high- quality assessments of healthcare professionals. It develops customized assessments for the medical specialty boards, other healthcare professions, and academic institutions, while online assessments help students and professionals identify their own strengths and weaknesses. The company was founded in 1915 and is headquartered in Philadelphia, PA. | Director/Board Member | - |
Training of Steven Galson
| Stony Brook University | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| VANDA PHARMACEUTICALS INC. | Health Technology |
| SCIENCE APPLICATIONS INTERNATIONAL CORPORATION | Technology Services |
| PROQR THERAPEUTICS N.V. | Health Technology |
| Private companies | 9 |
|---|---|
Leidos, Inc.
Leidos, Inc. Information Technology ServicesTechnology Services Leidos, Inc. provides scientific, engineering, systems integration and technical services and solutions. It offers solutions and services that leverage the power of data analytics, systems integration, and cyber security across national security, health, and engineering markets. The company was founded by John Robert Beyster in June 1969 and is headquartered in Reston, VA. | Technology Services |
| Environmental Protection Agency | Government |
US Department of Energy (District of Columbia)
 US Department of Energy (District of Columbia) General GovernmentGovernment US Department of Energy Develops energy technologies for buildings, homes, transportation power systems and industry. The company was founded in 1977 and is headquartered in Washington, DC. | Government |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
The National Board of Medical Examiners, Inc.
The National Board of Medical Examiners, Inc. Medical/Nursing ServicesHealth Services The National Board of Medical Examiners, Inc. provides services to the public through its high- quality assessments of healthcare professionals. It develops customized assessments for the medical specialty boards, other healthcare professions, and academic institutions, while online assessments help students and professionals identify their own strengths and weaknesses. The company was founded in 1915 and is headquartered in Philadelphia, PA. | Health Services |
| Center for Drug Evaluation & Research | Government |
| United States Environmental Protection Agency | Government |
InSilico Medicine Hong Kong Ltd.
 InSilico Medicine Hong Kong Ltd. Information Technology ServicesTechnology Services InSilico Medicine Hong Kong Ltd. operates as bioinformatics company, which utilizes advances in genomics, big data analysis and deep learning for silico drug discovery and drug repurposing for aging and age-related diseases. The company was founded by Alex Zhavoronkov and is headquartered in Hong Kong. | Technology Services |
Elephas Biosciences Corp.
Elephas Biosciences Corp. Medical/Nursing ServicesHealth Services Elephas Biosciences Corp. is a live tumor imaging company that provides cancer diagnostic solutions to predict treatment outcomes and accelerate drug development. The company is based in Madison, WI and was founded by Maneesh K. Arora, who has been the CEO since incorporation. The company's revolutionary diagnostic platform brings insights to cancer treatment decisions and accelerates immuno-oncology drug development. Investors can learn about clinical trials aimed at predicting responses to immunotherapy and how immunotherapeutic drug development can be accelerated with Elephas Biosciences's cybrid. | Health Services |
- Stock Market
- Insiders
- Steven Galson
